There was a significant correlation of VPS35 expression with tumor size (p = 0.01), lymph node metastasis (p = 0.006), and ER negative (p = 0.043), indicating that VPS35 was involved in breast cancer development (Fig. 5d, e and Table 3). Here, VPS35 is linked to breast carcinoma.